Guardant Health (GH) Cash from Operations Growth (3y) (2020 - 2026)
Guardant Health (GH) Cash from Operations Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 11.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -9.46% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 20.12% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -11.38% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.55% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 35.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 24.17% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.18% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.37% |
| 10 | Guardant Health | 21.59 Bn | 20.53 Bn | 219.03 Mn | 14.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.98% |
| Mar 31, 2026 | 4.12% |
| Dec 31, 2025 | 33.76% |
| Sep 30, 2025 | 23.19% |
| Jun 30, 2025 | 18.64% |
| Mar 31, 2025 | -29.87% |
| Dec 31, 2024 | 5.72% |
| Sep 30, 2024 | 1.33% |
| Jun 30, 2024 | -14.52% |
| Mar 31, 2024 | -22.96% |
| Dec 31, 2023 | -9.95% |
| Sep 30, 2023 | -112.94% |
| Jun 30, 2023 | -59.05% |
| Mar 31, 2023 | -77.63% |
| Dec 31, 2022 | -44.08% |
| Sep 30, 2022 | -291.54% |
| Jun 30, 2022 | -100.75% |
| Mar 31, 2022 | -88.06% |
| Dec 31, 2021 | -42.62% |
| Sep 30, 2021 | -34.08% |